| 发明名称 |
BIOMARKERS OF RESISTANCE TO HER2 INHIBITORS |
| 摘要 |
Provided is a method of suppressing resistance to an anticancer drug, comprising administering an inhibitor of expression or activity of ECM 1 (Extracellular Matrix Protein 1) to a cancer cell or an individual with cancer. |
| 申请公布号 |
US2014356349(A1) |
申请公布日期 |
2014.12.04 |
| 申请号 |
US201313908382 |
申请日期 |
2013.06.03 |
| 申请人 |
Seoul National University R&DB Foundation ;Industry-University Cooperation Foundation Hanyang University |
发明人 |
SHIN In-Cheol;LEE Tae-Hoon;JU Ji-Hyun;LEE Kyung-Min;YANG Won-Seok;NOH Dong-Young |
| 分类号 |
A61K39/395;G01N33/574;C12Q1/68 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of suppressing drug resistance in a patient suffering cancer resistant to an anticancer drug, comprising: administering an inhibitor of expression or activity of ECM 1(Extracellular Matrix Protein 1) to the patient. |
| 地址 |
Seoul KR |
